EA
IRWD icon

Emerald Advisers’s Ironwood Pharmaceuticals IRWD Stock Holding History

Emerald Advisers’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-456,770
Closed -$1.88M – 262
2024
Q3 		$1.88M Sell
456,770
-329,567
-42% -$1.77M 0.07% 122
2024
Q2 		$5.13M Sell
786,337
-36,412
-4% -$258K 0.22% 113
2024
Q1 		$7.17M Buy
+822,749
New +$9.98M 0.29% 106

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Emerald Advisers's IRWD Position: Q4 2024 in Review

Emerald Advisers sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2024, closing a stake of 456,770 shares — an estimated $1.88M sold.

Emerald Advisers first reported a position in IRWD in Q1 2024 and held it in 3 quarters. The position peaked at $7.17M in Q1 2024. 223 funds tracked by Wall St. Rank hold IRWD as of Q4 2024.

  • Emerald Advisers reported no remaining Ironwood Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Emerald Advisers sold 456,770 Ironwood Pharmaceuticals shares in Q4 2024, an estimated $1.88M.
  • Emerald Advisers first reported a position in Ironwood Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • Emerald Advisers's Ironwood Pharmaceuticals position peaked at $7.17M in Q1 2024.
  • 223 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2024.

Based on Emerald Advisers's 13F filing for Q4 2024, filed 11 Feb 2025.